Literature DB >> 433972

Plasmapheresis in the treatment of acute renal failure in multiple myeloma.

R Misiani, G Remuzzi, T Bertani, R Licini, P Levoni, A Crippa, G Mecca.   

Abstract

Three patients with multiple myeloma and severe acute renal failure were treated by repeated plasmapheresis. Recovery of renal function was observed in all. The pathogenetic role of light chains and the possible mechanisms responsible for renal damage are discussed. It is suggested that the removal of light chains by plasmapheresis may be of therapeutic value in this condition.

Entities:  

Mesh：

Year:  1979        PMID： 433972     DOI： 10.1016/0002-9343(79)91185-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

Review 2.  Onco-nephrology: AKI in the cancer patient.

Authors:  Albert Q Lam; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

Review 3.  Plasmapheresis in paraproteinemia.

Authors:  H H Euler; N Schmitz; H Löffler
Journal:  Blut       Date:  1985-06

Review 4.  Acute renal failure in the intensive care unit. Part 2.

Authors:  H L Corwin; J V Bonventre
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

5.  Plasmapheresis therapy in a patient with multiple myeloma.

Authors:  M Paul; F Walker; R A Bear
Journal:  Can Med Assoc J       Date:  1982-11-15       Impact factor: 8.262

Review 6.  [Therapeutic plasma exchange 1996].

Authors:  U Weber; W Riegel; H Köhler
Journal:  Med Klin (Munich)       Date:  1997-10-15

7.  [Successful treatment of kappa light chain nephropathy using membrane plasma separation].

Authors:  K B Sprenger; J Galle; I Sprenger-Klasen; J M Herrmann; H E Franz
Journal:  Klin Wochenschr       Date:  1984-10-01

8.  Treatment of acute renal failure due to myeloma kidney.

Authors:  R A Bear; E H Cole; A Lang; M Johnson
Journal:  Can Med Assoc J       Date:  1980-10-18       Impact factor: 8.262

9.  Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy.

Authors:  L Kleeberg; S Morgera; C Jakob; B Hocher; M Schneider; H Peters; S Rötzer; C Müller; M Kaiser; C Fleissner; U Heider; H-H Neumayer; O Sezer
Journal:  Eur J Med Res       Date:  2009       Impact factor: 2.175
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.